Recent polls indicate that a large majority of Americans favor stricter gun laws. But lately Congress has been moving in the opposite direction.
In December, the House of Representatives passed the Concealed Carry Reciprocity Act of 2017 (HR 38) which would generally allow persons who are authorized to carry a concealed handgun in one state to carry a handgun in other states even if the latter states have different eligibility requirements for concealed carry.
Not only that: The bill also provides for a private right of action so that the gun owner could sue any person or agency, apparently including a law enforcement agency, that interferes with his concealed-carry rights.
This provision “raises numerous legal questions,” the Congressional Research Service said in a brief new analysis. “For instance, what rights does the bill bestow, who may enforce them, and who may be sued for interfering with those rights?”
See Civil-Suit Provision in House-Passed Concealed Carry Reciprocity Bill (H.R. 38): Scope and Application, CRS Legal Sidebar, February 21, 2018.
These questions were also addressed at greater length in another new CRS publication. See Civil-Suit Provision in the House-passed Concealed Carry Reciprocity Act of 2017 (H.R. 38), CRS memorandum, February 20, 2018.
Other new and updated reports from the Congressional Research Service include the following.
FY2019 Budget: Government Reorganization and Federal Workforce Reform, CRS Insight, February 22, 2018
Pedal to the Metal: Commerce Recommends Revving Up Trade Measures on Steel and Aluminum, CRS Legal Sidebar, February 21, 2018
Bankruptcy and Student Loans, February 22, 2018
FY2018 Defense Spending Under an Interim Continuing Resolution, CRS In Focus, updated February 20, 2018
Defense Primer: Under Secretary of Defense for Research and Engineering, CRS In Focus, February 21, 2018
Defense Primer: Future Years Defense Program (FYDP), CRS In Focus, February 16, 2018
Commercial artificial intelligence tools have recently emerged that are able to produce police reports. If the resulting reports are inaccurate, incomplete or biased, or if the process leaks confidential information, this could undermine the criminal justice system and harm citizens.
Too often, affected patients, clinicians, and regulators cannot see how the system works, why a decision was made, or whether meaningful human oversight occurred.
Existing tools from other domains, such as existing robust public engagement processes in drug development, when applied to AI deployment can help strengthen public trust in these systems and enhance perceptions of their legitimacy and the decisions they produce.
With thoughtful policy action, it is still possible to build systems that are fair, transparent, and accountable, and to earn the public trust that will ultimately determine AI’s future. We hope policymakers are ready to act.